NBRG merger with Startech Group
Startech Group (United States)Pre-revenue: the filings show no meaningful actual revenue for the most recent reported period.
Announced 4 August 2026.
Startech Group Inc. is a U.S.-based Delaware corporation operating at the intersection of artificial intelligence, fintech, and life sciences technology. The company is structured around two complementary business segments: aquaporin functional water (AQP Water) and the StarOS platform, an agent operating system designed for the AI era. The AQP Water segment focuses on functional-water products and is expected to generate contractual per-bottle technology and settlement service revenue tied to product sales and digital product management. The StarOS segment represents Startech's AI platform business, intended to generate revenue from AI-enabled software and platform services. Together, these segments aim to blend consumer-product-related revenue opportunities with potentially scalable AI software and platform-based revenue streams, all oriented toward enhancing human health and longevity through AI-powered healthcare technologies.
Startech is going public via a definitive business combination agreement with Newbridge Acquisition Limited (Nasdaq: NBRGU), a blank-check company that raised $57.5 million in its January 2026 IPO. The all-stock transaction values Startech at approximately $1.0 billion, with Startech's stockholders and management set to receive 100,000,000 common shares of the combined entity. The deal has been unanimously approved by the boards of both companies, and Newbridge has secured support agreements from its sponsor, Wealth Path Holdings, as well as from certain Startech shareholders, committing them to vote in favor of the transaction and against alternatives. Prior to closing, Newbridge plans to re-domicile from the British Virgin Islands to Delaware, after which Newbridge Merger Sub will merge into Startech, making Startech a wholly owned subsidiary. The combined company plans to remain Nasdaq-listed under a new ticker symbol, with certain Startech shareholders subject to a six-month lock-up period following closing.
The rationale for the SPAC merger is to take Startech's AI platform public and scale its growth, leveraging the public markets to accelerate development of its dual business lines. The transaction remains subject to customary closing conditions, including shareholder approvals from both companies, SEC effectiveness of a Form S-4 registration statement, and Nasdaq approval of the combined company's listing application. Legal counsel for Newbridge includes Loeb & Loeb LLP and Forbes Hare, while Torres & Zheng Law, P.C. serves as legal counsel to Startech. The deal was announced on August 3, 2026, and positions Startech to capitalize on the convergence of consumer health products and AI-driven platform services in the public markets.
Structure & dilution
SEC-primary termsThe headline number ignores the shares that did not pay $10 — the founder promote, PIPE stock and warrants. This is the same deal with all equity claims counted.
Effective equity counts every claim on the post-close company at $10.00 — rollover, public shares, the founder promote and the PIPE. The headline counts only the target.
- Sponsor promote
- 20%
- Exchange ratio
All-stock: Aggregate Merger Consideration = $1,000,000,000 / US$10.00 = 100,000,000 Parent Common Shares issued to Startech's holders of common stock, options and convertible notes for all Aggregate Fully Diluted Company Common Stock.more ▾less ▴
Why headline and effective values differ is covered in headline vs effective deal value, in plain English.
The target: Startech Group Inc.
from 8-KThe business actually being bought — described from SEC primary filings, with projections labelled as projections.
Startech Group Inc. (Delaware corp, notice address 7700 Windrose, Plano, TX 75024; CEO Jack Yeung, whose e-mail runs on 'starcoininc.us') was incorporated on 29-Sep-2025 - about ten months before signing - and is being merged into Newbridge Acquisition Ltd (NBRG, a Hong-Kong-run BVI SPAC led by CEO Yongsheng Liu that IPO'd 2026-01-30) at a fixed $1,000,000,000 all-stock equity value (100,000,000 shares at $10.00, signed 2026-08-03). It describes two segments, both in the FUTURE tense: 'AQP Water' (aquaporin functional water, 'expected to generate contractual per-bottle technology and settlement service revenue') and 'StarOS', an 'agent operating system designed for the AI era' ('intended to generate revenue from AI-enabled software and platform services'). The only financial statements that exist are unaudited inception-to-30-Jun-2026 statements delivered privately under the BCA (not filed with the SEC); PCAOB audits are due only 60 days after signing. Pre-revenue by its own segment language, with no discoverable website, no named products in market, no customers, and no disclosed management beyond CEO Jack Yeung.
Founded 2025.
The filings show no meaningful actual revenue for the most recent reported period.
Startech Group Inc. — every SPAC that has bid for it, and its listed peers
Expensive or cheap?
vs 5 listed peersA price only means something next to what the same kind of business costs on the stock market. This divides what the buyers are paying by what Startech Group Inc. actually sells, and sets the answer against its closest listed comparables — or says plainly when that cannot be done.
SpacBrain’s read on the price
No multiple can be computed
Startech Group Inc. has no meaningful revenue yet, so no multiple is computable — this is priced on a story, not on financials. The deal still values it at $1.06bn.
The company reports no meaningful sales yet, so there is nothing to divide the price by.
Post-dilution equity (net debt unknown).
No meaningful revenue in the most recent reported period.
Not computable — the filings show no meaningful revenue for the most recent reported period.
$1 of their sales costs $4.26 on the open market. Median of 5 listed companies we judged a true comparable, which individually run from 2.12× to 9.66×. Their share prices are from 15 August 2026, not today.
What qualifies the figures above
- Struck on the post-dilution value of $1.06bn, not the announced $1bn — new shares handed to the sponsor, warrant holders and the PIPE are part of what public buyers are really paying.
- The target's cash and debt are not in the filings we have, so this is an equity value used as a stand-in for enterprise value.
- AMTB, BTFT, CARE, KCG, SELD have no revenue to divide by, so they are shown but left out of the peer median.
The 10 listed companies it is measured against, and why
- PRMB2.12× revenue
Primo Brands is the scaled North-American bottled/functional water benchmark - what real per-bottle water economics look like against Startech's aspirational per-bottle licensing fees.
- AMTBno revenue multiple
Operational comp: Corporate Banks; small-cap ($792m); shares statements, mail, customers, management, services, products with the target's own description; forward EV/Sales 4.7x.
- COCO4.93× revenue
Vita Coco - listed pure-play functional/premium beverage brand; the growth-brand comp for the AQP Water story.
- BTFTno revenue multiple
Operational comp: Investment Banking & Brokerage Services (NEC); shares ipo, kong, hong, was, ltd, financial with the target's own description; no forward EV/Sales published — counted as a peer, excluded from the median.
- CELH3.01× revenue
Celsius Holdings - the market's proof of what a genuinely scaling functional-beverage franchise earns and trades at; aspiration ceiling for AQP Water.
- CAREno revenue multiple
Operational comp: Corporate Banks; small-cap ($434m); shares statements, both, market, acquisition, from, are with the target's own description; forward EV/Sales 1.8x.
- AI4.26× revenue
C3.ai - listed enterprise-AI application platform; the comp for what StarOS claims to become (AI software/platform services revenue).
- KCGno revenue multiple
Operational comp: Investment Management & Fund Operators (NEC); shares kong, hong, group, financial with the target's own description; no forward EV/Sales published — counted as a peer, excluded from the median.
- BBAI9.66× revenue
BigBear.ai - small-cap AI platform company that de-SPAC'd; the realistic (rather than aspirational) valuation anchor for an unproven AI-platform story.
- SELDno revenue multiple
Operational comp: Investment Management & Fund Operators (NEC); shares ipo, pre, ltd, management, services, the with the target's own description; no forward EV/Sales published — counted as a peer, excluded from the median.
Which companies count as comparable is our judgement, written out above so you can disagree with it. The median is what these shares happened to trade at on the date given — not a price anyone is offering for this deal.
In plain English
No floor / floorlessthe cash guarantee is gone — the price is unprotected
A SPAC's downside protection is not the cash in trust; it is your right to demand that cash. Once the redemption window closes, the cash stays with the company and the share can trade anywhere.
Dilutionhow much of the company new shares take from you
Sponsor promote, PIPE shares, warrants and rights all issue stock that did not pay $10 for it. The headline deal value is before that; the effective value is after.
Pro-forma equitywhat the company is valued at once the deal closes
The combined company's equity value assuming the announced terms and the redemptions that have actually happened.
De-SPACthe day the SPAC becomes the real company
The shares stop being a claim on a pot of cash and start being equity in an operating business. Roughly 80% of recent de-SPACs traded below $10 within a year.
Outside datethe contractual long-stop for closing the deal
A deadline between the SPAC and its target, not between the SPAC and you. It confers no right to cash, which is exactly why it must never be counted as a redemption window.